NLRP3 and HIV-associated neurocognitive disorder: Chronic treatment with NLRP3 inhibitors like MCC950 has been shown to reduce neuroinflammation and neuronal injury in gp120 transgenic mice, signaling a potential therapeutic target for HAND [67,68].